ESR1 and breast cancer: A device generated by Landwehr et al. demonstrated that individual ER+ (MCF-7) and triple negative (MDA-MB-231) breast cancer cells respond differently when exposed to the same magnitudes and durations of FSS with some cells exhibiting greater deformability as the FSS rate and duration increased motivating the need for single cell studies22.